Eton Pharmaceuticals Launches Impavido Capsules to Treat Leishmaniasis

07:37 AM EDT, 09/28/2026 (MT Newswires) -- Eton Pharmaceuticals (ETON) said Monday that it launched Impavido (miltefosine) capsules to treat leishmaniasis, a parasitic disease, in adults and adolescents aged 12 and older weighing at least 30 kilograms. The company said its Eton Cares program will provide patient support services, including $0 co-pay for eligible commercially insured patients, while it works to expand hospital availability through a consignment inventory program. Eton also said it will offer an emergency access pathway for urgent patient needs through Anovo Specialty Pharmacy.